Trials / Completed
CompletedNCT05882383
Changes of Optical Quality During the Peak of the Covid-19 Pandemic
Changes of Optical Quality During the Peak of the Covid-19 Pandemic From November 2022 to January 2023 in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Tianjin Eye Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 32 Years
- Healthy volunteers
- Accepted
Summary
To explore whether cornea structure, and optical quality are affected by the covid-19 infection.
Detailed description
Participants with healthy corneas admitted to Tianjin Eye Hospital from November 25 to January 20, 2022 were followed up . At the end of the follow-up, the investigators recorded in detail whether the patients had undergone real-time reverse transcriptase polymerase chain reaction (covid-19 RT-PCR tests) testing, testing time and results. The presence of PCR-positive during follow-up is considered to be covid-19 infection; PCR-Negative and no symptoms of infection during the follow-up period are considered not infected; participants with symptoms but no PCR test were excluded from the study.Participants were divided into three groups according to the RT-PCR results and the presence or absence of symptoms of infection during follow-up. pentacam (Pentacam HR, Oculus, Wetzlar, Germany) was performed during follow-up and the results were recorded,and the data was statistically managed and compared.
Conditions
Timeline
- Start date
- 2022-11-25
- Primary completion
- 2023-01-20
- Completion
- 2023-01-20
- First posted
- 2023-05-31
- Last updated
- 2023-05-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05882383. Inclusion in this directory is not an endorsement.